Would it be worthwhile to monitor asymptomatic ablation patients suffering from heart failure more closely? JP, a 60-year-old man in good health, began experiencing intermittent weakness during physical activities, such as walking uphill, in 2021. Months passed and the weakness gradually worsened, which led JP to finally seek medical attention. The doctor diagnosed a heart …
Text from CEO Weekly, June 26, 2025: https://ceoweekly.com/convenience-accuracy-prevention-how-a-wrc-rally-legend-found-his-rhythm-with-pulseon/ Convenience, Accuracy, & Prevention How a WRC Rally Legend Found His Rhythm with PulseOn Contrary to what’s on the surface, PulseOn is not a smartwatch. Developed by a team specializing in high-tech and analysis software for medical use, this end-to-end solution redefines how doctors diagnose, monitor, and …
EHRA2025 started in Vienna! PulseOn guys Jaakko and Markku will be your humble servants for the next three days. Please visit stand B140 for a tailored presentation of the efficient and easy long-term arrhythmia monitoring wearable.
ESC2024 starting this week! To hear about PulseOn 24/7 monitoring solution for easy silent AFib detection, please meet us at booth F360. See you soon in London.
EHRA2024 starting this weekend. Come and learn how to detect even the hard-to-find asymptomatic arrhythmias with PulseOn solution.See you in Berlin, stand B510.
AHA Scientific Sessions 2023 started! A great opportunity to visit PulseOn stand #3120 to hear about new technology to remotely monitor AFib for long periods without disturbing patient’s everyday life.
PulseOn is at ESC Congress 2023 in Amsterdam, 25 – 28 August 2023.To hear about the latest technology in Atrial Fibrillation detection, please visit our stand at the Digital Health Area (DH17).
PulseOn is chosen as a Top 12 Wearables Techpreneur 2023 in the WT Innovation World Cup®. More than 600 startups, scale-ups, and ground-breaking tech founders and SMEs worldwide submitted their solutions in the Innovation World Cup®. The selected Top 12 companies will present their solutions at the pitch and award ceremony at the 43rd Wearable …
PulseOn’s latest clinical trial article was published in Frontiers in Cardiovascular Medicine on Feb 9, 2023. Wrist-worn device combining PPG and ECG can be reliably used for atrial fibrillation detection in an outpatient setting.(Harri Saarinen et al.) In this article we demonstrated the performance of our wrist-worn solution in detecting atrial fibrillation. The participating doctors …
Frontiers in Cardiovascular Medicine publication Read More »
PulseOn is a top 12 finalist in the 14th Healthcare Innovation World Cup® The 14th Healthcare Innovation World Cup® received around 300 submissions from start-ups, scale-ups, and SMEs worldwide. The Top12 Health Techpreneurs 2022 present their solutions in an exciting pitch final with live jury evaluation. Held at MEDICA, Düsseldorf, on Monday, 14th of November, 13:00 – …
